Medtronic plc, a global leader in healthcare technology, has announced the spin-off of its Diabetes business, which will operate under the historic name MiniMed. The decision pays homage to MiniMed's origins before being acquired by Medtronic in 2001. The new company, based in Northridge, California, comprises over 8,000 employees dedicated to innovating diabetes care. The separation is expected to be completed within 18 months, subject to customary conditions and legal requirements. The move aims to enhance focus on developing breakthrough technologies that improve quality of life and redefine diabetes care standards.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。